Pam Murphy | IR |
Bill Collier | President and CEO |
Dave Hastings | CFO |
Gaston Picchio | Chief Development Officer |
Mike Sofia | Chief Scientific Officer |
Mayank Mamtani | B. Riley |
Keay Nakae | Chardan |
Madhu Kumar | Robert W. Baird |
Ladies and gentlemen, thank you for standing by, and welcome to the Arbutus Biopharma Corporation Fourth Quarter and Year-End 2019 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions]